glp 1 nomi commerciali GLP-1 e farmaci agonisti del GLP-1: cosa sono e come funzionano Farmaci anti-obesità: quali effetti su

Sahoo T, del Gaudio D, German JR et al : Prader-Willi phenotype caused by paternal deficiency for the HBII-85 C/D box small nucleolar RNA cluster

1 Dual agonism of GIP and GLP-1 receptors is a promising new approach currently in clinical development for the treatment of diabetes, obesity, and associated complications [1] The incretin effect defines the main physiological role of GIP and GLP-1 GIP and GLP-1 increase insulin secretion following nutrient-induced secretion from the gut (incretin effect): There is a stronger insulin secretion response to oral compared to 'isoglycemic' intravenous glucose administration due to secretion and action of incretin hormones

Cell 188, 64246435.e17

Appetite Regulation : GLP-1 therapy influences appetite-related hormones, reducing cravings and helping you control portion sizes